Literature DB >> 6442123

Recognition and clinical significance of mechanisms of bacterial resistance to beta-lactams.

R P Mouton.   

Abstract

Resistance to beta-lactams may be difficult to recognize. This is due to the difficulty in detecting these resistances, when the routine tests performed in diagnostic laboratories are interpreted in the usual manner. Since failure to recognize this type of resistance may have serious consequences for the patient, it is essential that it be detected when present. For the detection of methicillin resistance of Staphylococcus aureus a standardized method using either a medium containing 5% NaCl or a low incubation temperature is advocated. Methicillin resistance of S. epidermidis can only be recognized reliably by means of a quantitative test and incubation for 42-48 h. Resistance of Haemophilus influenzae to ampicillin may be intrinsic or it may be caused by a TEM beta-lactamase; a beta-lactamase test should be used to detect the latter type of resistance. Inducible cephalosporinase may be responsible for the rapid development of resistance of some bacterial species to cefamandole, even during therapy. If a stable beta-lactamase production is attained by mutation, resistance to other beta-lactams will usually be present as well. Routine induction tests should be performed for all isolates of species of Enterobacter, Serratia, Citrobacter and Proteus, indole-positive. The same type of 'hidden' resistance may be present in Pseudomonas aeruginosa, with regard to cefotaxime and other third-generation cephalosporins. Beta-lactamase-positive Neisseria gonorrhoeae can easily be recognized by a beta-lactamase test. In addition, the results of diffusion tests allow one to distinguish between beta-lactamase-positive and beta-lactamase-negative strains. Recognition of those strains of N. gonorrhoeae having a decreased susceptibility to penicillin is only possible when well-standardized quantitative tests are used.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6442123     DOI: 10.1007/bf02386236

Source DB:  PubMed          Journal:  Antonie Van Leeuwenhoek        ISSN: 0003-6072            Impact factor:   2.271


  110 in total

1.  The effect of penicillin on growth and toxin production by enterotoxic staphylococci.

Authors:  M SEGALOVE
Journal:  J Infect Dis       Date:  1947 Nov-Dec       Impact factor: 5.226

2.  Detection of methicillin resistance in cultures of Staphylococcus aureus.

Authors:  D I Annear
Journal:  Lancet       Date:  1970-07-04       Impact factor: 79.321

3.  Effects of beta-lactamase from gram-negative organisms on cephalosporins and penicillins.

Authors:  C H O'Callaghan; P W Muggleton; G W Ross
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1968

4.  Novel resistance selected by the new expanded-spectrum cephalosporins: a concern.

Authors:  C C Sanders
Journal:  J Infect Dis       Date:  1983-03       Impact factor: 5.226

5.  Resistance to cefamandole: derepression of beta-lactamases by cefoxitin and mutation in Enterobacter cloacae.

Authors:  T D Gootz; C C Sanders; R V Goering
Journal:  J Infect Dis       Date:  1982-07       Impact factor: 5.226

6.  Evidence for two distinct types of penicillinase-producing Neisseria gonorrhoeae.

Authors:  P L Perine; C Thornsberry; W Schalla; J Biddle; M S Siegel; K H Wong; S E Thompson
Journal:  Lancet       Date:  1977-11-12       Impact factor: 79.321

7.  Standardization of antibiotic sensitivity tests.

Authors:  R P Mouton; B van Klingeren
Journal:  Scand J Infect Dis       Date:  1982

8.  Comparison of activity and beta-lactamase stability of cefotaxime with those of six other cephalosporins.

Authors:  R P Mouton; G P Bongaerts; M van Gestel
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

9.  A comparative study of the activity of cefamandole and other cephalosporins and analysis of the beta-lactamase stability and synergy of cefamandole with aminoglycosides.

Authors:  K P Fu; H C Neu
Journal:  J Infect Dis       Date:  1978-05       Impact factor: 5.226

10.  Antibiotic therapy of experimental Staphylococcus epidermidis endocarditis.

Authors:  G J Vazquez; G L Archer
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.